US20020082691A1 - Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses - Google Patents
Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses Download PDFInfo
- Publication number
- US20020082691A1 US20020082691A1 US09/875,410 US87541001A US2002082691A1 US 20020082691 A1 US20020082691 A1 US 20020082691A1 US 87541001 A US87541001 A US 87541001A US 2002082691 A1 US2002082691 A1 US 2002082691A1
- Authority
- US
- United States
- Prior art keywords
- approximately
- polymer
- siloxane units
- reinforcer
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/04—Polysiloxanes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/04—Polysiloxanes
- C08G77/32—Post-polymerisation treatment
- C08G77/34—Purification
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/34—Silicon-containing compounds
- C08K3/36—Silica
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
Definitions
- Intraocular lenses made from silicone polymeric materials are usually deformable, so that for implantation a smaller incision needs to be surgically out in the eye than for the implantation of “hard” intraocular lenses.
- the size and mechanical characteristics of the silicone polymeric intraocular lenses play an important role.
- the lens rust have sufficent structural integrity, elasticity and small enough size to permit the folding for insertion through a small incision. After insertion, the lens must, of course, regain its original molded shape.
- the thinner is the lens, the easier is the surgical insertion procedure.
- the lens material in order to function as an intraocular lens, the lens material must have sufficient optical refractory power. Consequently, the higher is the optical refractive index of the silicone material, the thinner can be the lens to obtain the same optical refractory power.
- Some silicone polymeric materials described in the prior art contain a silica reinforcer finely distributed in the polymeric silicone resin. Usually such reinforcement of the silicone polymeric material with silica is necessary for the polymeric material to attain adequate structural strength to be used as a foldable intraocular lens.
- silica reinforced polymeric silicone resins suitable for use as soft contact or intraocular lenses are described in U.S. Pat. Nos. 3,996,187; 4,615,702; 3,996,189. Additional disclosures relating to polymeric silicone materials or silica reinforcers, which comprise the background of the present invention can be found in U.S. Pat. Nos. 3,341,490; 3,284,406; 3,457,214; and in European Patent Application No. 0110537 filed on Oct. 18, 1983.
- an optically clear, reinforced cross-linked silicone elastomer which includes a polymer containing 12 to 18 mol percent of aryl substituted siloxane units of the formula R 4 ,R 5 —Si—O.
- R 4 and R 5 are identical with one another or are different from one another and represent phenyl, or mono- lower alkyl substituted phenyl groups, or di- lower alkyl substituted phenyl groups.
- both R 4 and R 5 are phenyl.
- the polymer has end blockers containing siloxane units of the formula R 1 ,R 2 ,R 3 —Si—O wherein R 1 and R 2 are alkyl, aryl or substituted alkyl or substituted aryl groups, and R 1 and R 2 may be identical or different from one another.
- the end blocker is a dimethylvinyl siloxane unit.
- the balance of the polymer consists of dialkyl siloxane units of the formula R 6 ,R 7 —Si—O wherein R 6 and R 7 are identical with one another or are different from one another and are methyl or ethyl groups, and the polymer has a degree of polymerization approximately between 100 to 2000.
- the R 6 and R units are both methyl, and the degree of polymerization is approximately 250.
- a trimethyl silyl treated silica reinforcer is finely dispersed in the polymer, in a weight ratio of approximately 15 to 45 parts of the reinforcer to 100 parts of the polymer. Preferably, there is approximately 27 parts of reinforcer to 100 parts of the copolymer.
- the polymer when cured by cross-linking in a mold forms the body of an intraocular lens of the invention, and has the properties of an optical refractive index which is at least 1.44, a type A durometer hardness value of at least 35, a tensile strength of at least 500 psi, and a tear strength of at least 20 pli.
- Reinforced elastomeric polysiloxane copolymer compositions are provided in accordance with the present invention, which after appropriate curing by cross-linking, are eminently suitable to serve as the body of foldable “soft” intraocular lenses capable of implantation through a small incision in the eye.
- the reinforced elastomeric composition of the present invention has the chemical composition of a cross-linked copolymer including approximately 12 to 18 mol per cent of aryl substituted siloxane units of the formula R 4 , R 5 —Si—O where the aryl substituents (R 4 and R 5 groups) can be phenyl groups, mono- lower alkyl substituted phenyl groups, or di- lower alkyl substituted phenyl groups, and can be identical with one another or different from one another.
- both aryl groups are simple phenyl, and the resulting diphenyl siloxane unit is present in the copolymer in a ratio of approximately 14 to 16 mol per cent.
- the diphenyl siloxane unit content of the copolymer is approximately 15 mol per cent.
- the copolymer is end blocked with trisubstituted (monofunctional) siloxane units, an important feature of which is that at least one substituent of the end blocking group contains an olefenic bond.
- the general formula of the end blocking group incorporated in the copolymer of the invention in R 1 ,R 2 ,R 3 —Si—O where the nature of the R 1 and R 2 is not critical, and they may be, for example, alkyl, aryl, or substituted alkyl or substituted aryl groups.
- R 1 and R 2 may be identical to one another, and may also be different from one another.
- the nature of the R 3 group is important in that R 3 contains an olefenic bond.
- R 3 is an alkenyl group, preferably a vinyl group.
- the end blocking group is a dimethyl, vinyl siloxane unit.
- the role of the olefenic (vinyl) group, is to enable curing or cross-linking of the polymer an well as covalently linking, in accordance with another feature, certain ultraviolet light absorbing compounds to the cross-linked copolymer matrix of an intraocular lens made in accordance with the invention.
- the balance of the siloxane building blocks of the copolymer are dialkyl siloxane units wherein the two alkyl substituents are either ethyl or methyl.
- the general formula of the balance of the siloxane building blocks of the copolymer is R 6 ,R 7 —Si—O where the R 6 and R 7 groups are methyl or ethyl and the two groups are either identical with one another, or are different from one another.
- both R 6 and R 7 groups are methyl.
- the copolymer having the above-described components has a degree of polymerization (dp) of approximately 100 to 2000, although a degree of polymerization of approximately 250 is preferred particularly when the R 4 and R 5 groups are phenyl and the R 6 and R 7 groups are methyl.
- cyclic oligomers of the components and suitable state-of-the-art precursors of the end blocking groups are reacted in the presence of a suitable catalyst to achieve polymerization to the desired degree.
- the cyclic oligomer starting materials are beat exemplified by reference to the specific example of the moat preferred embodiment of the copolymer of the invention.
- a mixture of octophenylcyclo-tetrasiloxane, octanethylcyclo-tetrasiloxane and 1,2 divinyltetramethyldisiloxane are reacted in the presence of a polymerization catalyst to achieve a degree of polymerization which is approximately 250 for the preferred embodiment.
- the selection of suitable starting materials for the polymerization is within the skill of the ordinary artisan.
- the polymerization can be conducted by using state of the art catalyst; the well known N-catalysts and K-catalysts are particularly of choice in this regard.
- the K-catalysts used for polysiloxane formation comprise potassium hydroxide
- the N-catalysts comprise tetromethylammonium hydroxide.
- the degree of polymerization is monitored by monitoring the viscosity of the reaction mixture.
- the optical refractive index of the reaction mixture is also monitored, and the reaction is not considered completed, nor giving acceptable product unless the reaction mixture has a viscosity within a desired range and an optical refractive index of at least 1.44.
- the desired viscosity range depends on the nature and composition of the copolymer; for the preferred copolymer having dimethylvinylailoxane end blockers, approximately 15 mol per cent diphenyl siloxane building blocks with the balance being dimethylsiloxane, and a degree of polymerization of approximately 250, the desired viscosity range of the reaction product is approximately 2000 to 2800 centipoise (cp).
- cp centipoise
- the catalyst is inactivated, neutralized, or removed and the reaction product is carefully filtered, for example on a filter press, to remove any unreacted solid starting materials or other solid impurities.
- volatile materials are carefully removed from the copolymer by repeated exposure to vacuum, preferably while the copolymer is in a thin film form.
- the careful removal of volatiles commonly termed “stripping”, is consired important for the purpose of obtaining material suitable for use as intraocular lens.
- the “stripping” is preferably conducted in a state-of-the-art “wipe film evaporator” using large “wipe films” and the process is monitored by gas column chromatography of the removed volatiles.
- the removed “volatiles” are residues of starting materials, cyclic and linear oligosiloxanes and the like.
- the crude reaction product copolymer of the present invention also contains products having substantially lesser degree of polymerization, than for example the desired dp of 250 for the preferred embodiment.
- a dp of 250 of the preferred embodiment is to be construed as such dp numbers are normally construed in the art of polysiloxane chemistry.
- a dp of 250 thus means that the average dp of the polymeric product is approximately 250 .
- Stripping of the copolymeric product is repeated several times, preferably three times. This process removes a significant amount of the lower dp copolymers; usually approximately 12 percent by weight of the reaction product is removed by “stripping”.
- the refractive index of the copolymer should be at least 1.44.
- the desired viscosity depends on the precise nature of the copolymer, for the preferred embodiment the viscosity of the “stripped” copolymer should be approximately 4100 to 5300 cp.
- the elastomeric composition of the present invention contains a trimethylsilyl treated silica reinforcer finely dispersed in the copolymer. Blending trimethylsilyl treated “fume silica” into a polysiloxane copolymer for the purpose of improving the mechanical porperties of the resulting composition per se, is not new in the art. Nevertheless, the composition of the present invention is considered novel and highly unobvious because of the hitherto unattained highly desirable optical and mechanical properties of the reinforced composition.
- the fume silica reinforcer is used in a ratio of approximately 15 to 45 parts by weight of the reinforcer to 100 parts of the copolymer.
- Fume silica itself is commercially available. Processes for trimethylsilylating the surface of fume silica for the purpose of rendering the silica surface hydrophobic and compatible with polysiloxane polymers are also known and within the skill of the ordinary artisan.
- U.S. Pat. Nos. 3,341,490 and particularly 3,036,985 refer to and describe such processes for trimethylsilylating fume silica, and the specifications of these two patents are expressly incorporated herein by reference.
- the fume silica reinforcer used for the composition has a surface area of approximately 100 to 450 meter 2 /gram.
- the fume silica has a surface area of approximately 200 meter 2 /gram, is present in a weight ratio of approximately 27 parts to 100 parts of the copolymer, and is preferably trimethylsilylated with hexamethyldisilazone substantially in the same step where the copolymer is intimately mixed with the silica.
- the intimate mixing is preferably aided by treating the mixture on a roll mill or like device. After intimate mixing, volatiles, such as unreacted silylating agent, gaseous by-products and water are removed from the mixture by heat and vacuum.
- the intimate mixture of the trimethylsilylated fume silica with the copolymer is commonly termed “base” in the art.
- the base is dispersed in a suitable inert solvent, such as trichlorotrifluoroethene (FREON) and the dispersion is filtered to remove any solid impurities. Thereafter, the solvent is removed by gentle heat and vacuum.
- FREON trichlorotrifluoroethene
- the resulting, volatile free uncured (not yet cross-linked) and optically clear reinforced silicone elastomer base has in accordance with the present invention, an optical refractive index of at least 1.44 and a viscosity in such a range which permits intimate mixing of the base with suitable catalyst and cross linking agents, and subsequent manipulation for forming, preferably by molding, into intraocular lenses.
- the acceptable viscosity range for this purpose is approximately 35,000 to 80,000 cp.
- the refractive index of the uncured base is approximately 1.462 ⁇ 0.003 and the viscosity is in the range of 35,000 to 70,000 cp.
- the uncured base has the inherent characteristics of providing, after suitable curing by cross-linking, physical properties which are highly advantageous for a soft intraocular lens.
- the properties of the resulting cross-linked elastomer include in accordance with the present invention the following:
- optical refractive index which is at least 1.44
- the above listed properties can be measured in accordance with state-of-the-art technology and instruments in accordance with the respective requirements of standard ASTM test methods. More particularly, the durometer test is performed as ASTM D2240, the tensile and elongation tests as ASTM D412 and the tear strength test as ASTM D624 Die B.
- the optical refractive index of the cross linked elastomer obtainable from the base is approximately 1.462
- the durometer hardness is approximately between 38 to 40
- the tensile strength is approximately between 700 to 750 psi
- the tear strength is approximately 40 pli.
- cross-linking tends to slightly increase the optical refractive index as compared to the uncured base.
- Preparation of the uncured base for cross-linking is accomplished as follows.
- the base is filtered once more, preferably through a 325 mesh screen to remove any remaining solid impurities. Thereafter, in accordance with standard practice in the art, the base is divided into two aliquots which preferably are of equal weight. The aliquots are commonly termed “Part A” and “Part B”, or first and second aliquot parts.
- cross-linking is accomplished by utilizing in a platinum catalyzed reaction the terminal silicon bonded olefinic (vinyl) groups of the base, and silicon bonded hydrogen groups.
- the silicon bonded olefinic (vinyl) groups are present both in the first and second aliquots of the base.
- Silicon bonded hydrogen groups are added in the practice of the present invention to the second aliquot (Part B) in the form of suitable cross-linking agents.
- the cross-linking agents per se are known in the art, and may be made in accordance with the teachings of U.S. Pat. No. 3,436,366 the specification of which is incorporated herein by reference.
- liquid organohydrogen polysiloxane cross linkers shown in column 2 of the above-noted U.S. Pat. No. 3,436,366 and having the formula (R) a (H) b SiO 4-a-b/2 wherein R is simple lower alkyl and a ranges from 1.00 to 2.10 and b ranges from 0.1 to 1.0, are eminently suitable.
- Particularly suitable is the liquid organohydrogen polysiloxane cross-linker of the above-referenced U.S. Pat. No. 3,436,366 having the formula R 2 HSiO 1 ⁇ 2 , and the liquid cross linker described in Column 4 lines 3-14 of said patent reference wherein the R groups are primarily or predominantly methyl.
- the platinum catalyst can also be selected within the skill of the ordinary artisan, primarily from organo platinum compounds, for example in accordance with the specifications of U.S. Pat. Nos. 2,823,218 and 3,159,601, which are expressly incorporated herein by reference.
- the platinum catalyst is added to the first aliquot (Part A).
- Parts A and Parts B it is important in accordance with the invention that after mixing of the aliquots (Parts A and Parts B), the cross-linking should not proceed too rapidly at room temperature, thereby allowing at least two, preferably approximately six hours for work time with the mixed aliquots. For this reason, a suitable cross-linking inhibitor, such as 1,2,3,4 tetramethyl-1,2,3,4-tetramethyl cyclotetrasiloxane, is also added to the second aliqout (Part B).
- a suitable cross-linking inhibitor such as 1,2,3,4 tetramethyl-1,2,3,4-tetramethyl cyclotetrasiloxane
- the organo platinum catalyst is added to the first aliquot in 12 part per million (12 ppm) by weight.
- the cross-linker is added to the second aliquot in the range of approximately 1 to 6 parts per hundred (1-6 pph) by weight.
- the above specified inhibitor is also added to the second aliquot in the range of 0.01 to 0.2 parts per hundred by weight.
- an ultraviolet ray absorbing material is also optionally mixed into the second aliquot in accordance with the teachings of co-pending application for U.S. patent Ser. No. 946,703 filed on Dec. 24, 1986 by Reich et, al, and titled ULTRAVIOLET LIGHT ABSORBING SILICONE COMPOSITIONS.
- the ultraviolet ray absorbing material which in accordance with teachings of the above-noted patent application is a vinyl functional 2-hydroxybenzophenone, or a vinyl functional benzotriazole is covalently linked to the copolymer of the composition during the cross linking step.
- the ultraviolet absorbing material is 2(2′-hydroxy-3′-t-butyl-5′-vinyl-phenyl)-5-chloro-2H-benzotriazole, and is added in an amount of approximately 0.5 weight percent to the second aliquot, Consequently, in the final cured elastomer, the above-named u. v. absorbent is present in approximately 0.25 per cent (by weight).
- the vinyl functional u. v. absorbant reacts with the organohydrogen polysiloxane cross-linking agent in essentially the same way as the vinyl group of the copolymer, and forms a carbon to silicone bond which covalently links the u. v. absorber to the copolymer network.
- Formation of intraocular lens bodies from the elastomeric compositions of the present invention may be accomplished by liquid injection molding or by coat or compression molding of the intimately mixed first and second aliquots. Although these processes are well known in the art, they are briefly summarized by description of the following examples.
- the mixed aliquots are injected into a hot mold kept at approximately 120 to 150 C.
- the cross-linking or curing process is then complete in approximately five minutes.
- the mixed aliquots are placed into appropriate molds, and the molds are thereafter positioned in an oven heated to approximately 150 C. Under these conditions the cure is complete in approximately 15 to 30 minutes.
- the cast molding process can also be completed at room temperature in significantly longer time periods.
- the intraocular lenses made in accordance with the present invention have the above-described advantagous optical and Mechanical properties.
- the unusually high optical refractive index of 1.44 or greater permits the fabrication of lenses which are at their apex only approximately 1.1 to 1.15 mm thick. This is a significant advance over prior art intraocular lenses which, being made of materials having lower refractive indices, at typically are 1.42 mm thick at their apex.
- An additional advantage of the intraocular lenses made in accordance with the invention is that they do not absorb energy at 1064 nm, thereby permitting follow-up LASER surgery in the eye after implantation of the lens.
- N-Catalyst 0.18 per cent more N-Catalyst (about 75 g). After viscosity change has been observed and the phenyl cyclics have dissolved continue heating and stirring for 3 hours. Then neutralize or destroy the catalyst, for example by bubbling CO 2 into the mixture, or heating to 150 C. Viscosity of the cooled reaction mixture should be between 2000 to 2800 cp, the refractive index should be between 1.459 to 1.465.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Physics & Mathematics (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Materials Engineering (AREA)
- Composite Materials (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- General Physics & Mathematics (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
Description
- Intraocular lenses made from silicone polymeric materials are usually deformable, so that for implantation a smaller incision needs to be surgically out in the eye than for the implantation of “hard” intraocular lenses. In this respect, the size and mechanical characteristics of the silicone polymeric intraocular lenses play an important role. As it will be well understood by those skilled in the art, for successful implantation the lens rust have sufficent structural integrity, elasticity and small enough size to permit the folding for insertion through a small incision. After insertion, the lens must, of course, regain its original molded shape.
- It will be further understood by those skilled in the art that the thinner is the lens, the easier is the surgical insertion procedure. On the other hand, in order to function as an intraocular lens, the lens material must have sufficient optical refractory power. Consequently, the higher is the optical refractive index of the silicone material, the thinner can be the lens to obtain the same optical refractory power.
- Some silicone polymeric materials described in the prior art contain a silica reinforcer finely distributed in the polymeric silicone resin. Usually such reinforcement of the silicone polymeric material with silica is necessary for the polymeric material to attain adequate structural strength to be used as a foldable intraocular lens. Such silica reinforced polymeric silicone resins suitable for use as soft contact or intraocular lenses are described in U.S. Pat. Nos. 3,996,187; 4,615,702; 3,996,189. Additional disclosures relating to polymeric silicone materials or silica reinforcers, which comprise the background of the present invention can be found in U.S. Pat. Nos. 3,341,490; 3,284,406; 3,457,214; and in European Patent Application No. 0110537 filed on Oct. 18, 1983.
- Additional disclosures relating to intraocular lenses can be found in U.S. Pat. No. 4,573,998, published UK Patent Application GB 2114315, and in co-pending application for U.S. patent Ser. No. 946,703 filed on Dec. 24, 1986 by Reich et. al. The latter U.S. patent application is assigned to one of the co-assignees of the present applications
- The prior art intraocular lenses made of silica reinforced silicone copolymers still do not fully satisfy the need for high enough optical refractory power to permit sufficently thin lens size which in turn would make it possible to surgically implant the lens through a desirably small incision in the eye. In other words, there is still need in the art for reinforced silicone polymeric materials which have sufficiently high optical clarity, refractive index, durometer hardness, tensile strength and related mechanical properties to permit construction of thin foldable intraocular lenses. The present invention satisfies this need.
- It is an object of the present invention to provide optically clear reinforced silicone polymeric materials of a refractive index of at least 1.44 coupled with sufficient durometer hardness, tensile strength and other mechanical properties to permit forming of thin intraocular lenses through final cross-linking of the polymeric material into desired lens shapes.
- It is another object of the present invention to provide a thin intraocular lens body from a reinforced silicone polymeric material, wherein the lens body has an optical refractive index of at least 1.44 and sufficient mechanical properties to permit implantation through a small incision in the eye.
- The foregoing objects and advantages are attained by an optically clear, reinforced cross-linked silicone elastomer which includes a polymer containing 12 to 18 mol percent of aryl substituted siloxane units of the formula R4,R5—Si—O. In the formula R4 and R5 are identical with one another or are different from one another and represent phenyl, or mono- lower alkyl substituted phenyl groups, or di- lower alkyl substituted phenyl groups. Preferably both R4 and R5 are phenyl.
- The polymer has end blockers containing siloxane units of the formula R1,R2,R3—Si—O wherein R1 and R2 are alkyl, aryl or substituted alkyl or substituted aryl groups, and R1 and R2 may be identical or different from one another. The R3 group of the end blocking siloxane units in an alkenyl group. Preferably, the end blocker is a dimethylvinyl siloxane unit.
- The balance of the polymer consists of dialkyl siloxane units of the formula R6,R7—Si—O wherein R6 and R7 are identical with one another or are different from one another and are methyl or ethyl groups, and the polymer has a degree of polymerization approximately between 100 to 2000. Preferably, the R6 and R units are both methyl, and the degree of polymerization is approximately 250.
- A trimethyl silyl treated silica reinforcer is finely dispersed in the polymer, in a weight ratio of approximately 15 to 45 parts of the reinforcer to 100 parts of the polymer. Preferably, there is approximately 27 parts of reinforcer to 100 parts of the copolymer.
- The polymer when cured by cross-linking in a mold forms the body of an intraocular lens of the invention, and has the properties of an optical refractive index which is at least 1.44, a type A durometer hardness value of at least 35, a tensile strength of at least 500 psi, and a tear strength of at least 20 pli.
- Further objects and advantages of the present invention will become readily apparent from the ensuing description wherein the specific embodiments are described as follows.
- Reinforced elastomeric polysiloxane copolymer compositions are provided in accordance with the present invention, which after appropriate curing by cross-linking, are eminently suitable to serve as the body of foldable “soft” intraocular lenses capable of implantation through a small incision in the eye.
- More particularly, the reinforced elastomeric composition of the present invention has the chemical composition of a cross-linked copolymer including approximately 12 to 18 mol per cent of aryl substituted siloxane units of the formula R4, R5—Si—O where the aryl substituents (R4 and R5 groups) can be phenyl groups, mono- lower alkyl substituted phenyl groups, or di- lower alkyl substituted phenyl groups, and can be identical with one another or different from one another. Preferably, both aryl groups are simple phenyl, and the resulting diphenyl siloxane unit is present in the copolymer in a ratio of approximately 14 to 16 mol per cent. In the hereinafter described specific example, the diphenyl siloxane unit content of the copolymer is approximately 15 mol per cent.
- It is noted in connection with the diaryl, preferably simple diphenyl substituted siloxane units, that the presence of the aryl groups tends to increase the optical refractive index of the copolymer.
- The copolymer is end blocked with trisubstituted (monofunctional) siloxane units, an important feature of which is that at least one substituent of the end blocking group contains an olefenic bond. Thus, the general formula of the end blocking group incorporated in the copolymer of the invention in R1,R2,R3—Si—O where the nature of the R1 and R2 is not critical, and they may be, for example, alkyl, aryl, or substituted alkyl or substituted aryl groups. R1 and R2 may be identical to one another, and may also be different from one another. The nature of the R3 group is important in that R3 contains an olefenic bond. Thus, R3 is an alkenyl group, preferably a vinyl group. In the preferred embodiment of the invention the end blocking group is a dimethyl, vinyl siloxane unit. The role of the olefenic (vinyl) group, is to enable curing or cross-linking of the polymer an well as covalently linking, in accordance with another feature, certain ultraviolet light absorbing compounds to the cross-linked copolymer matrix of an intraocular lens made in accordance with the invention.
- The balance of the siloxane building blocks of the copolymer are dialkyl siloxane units wherein the two alkyl substituents are either ethyl or methyl. In other words, the general formula of the balance of the siloxane building blocks of the copolymer is R6,R7—Si—O where the R6 and R7 groups are methyl or ethyl and the two groups are either identical with one another, or are different from one another. Preferably in the practice of the present invention both R6 and R7 groups are methyl.
- In accordance with the present invention the copolymer having the above-described components has a degree of polymerization (dp) of approximately 100 to 2000, although a degree of polymerization of approximately 250 is preferred particularly when the R4 and R5 groups are phenyl and the R6 and R7 groups are methyl.
- Except to the extent that novel features are emphasized below, the preparation of the copolymer having the above described components can be performed in accordance with processes known in the art, from starting materials which are either commercially available or can be made in accordance with well known state-of-the-art processes.
- Thus, in accordance with standard practice in the art, readily available cyclic oligomers of the components and suitable state-of-the-art precursors of the end blocking groups are reacted in the presence of a suitable catalyst to achieve polymerization to the desired degree. The cyclic oligomer starting materials are beat exemplified by reference to the specific example of the moat preferred embodiment of the copolymer of the invention. Specifically, a mixture of octophenylcyclo-tetrasiloxane, octanethylcyclo-tetrasiloxane and 1,2 divinyltetramethyldisiloxane are reacted in the presence of a polymerization catalyst to achieve a degree of polymerization which is approximately 250 for the preferred embodiment.
- It should be specifically understood in connection with the preparation of the copolymer that after the proper copolymer composition is selected, the selection of suitable starting materials for the polymerization is within the skill of the ordinary artisan. Similarly, the polymerization can be conducted by using state of the art catalyst; the well known N-catalysts and K-catalysts are particularly of choice in this regard. As is known in the art, the K-catalysts used for polysiloxane formation comprise potassium hydroxide, whereas the N-catalysts comprise tetromethylammonium hydroxide.
- It is an important aspect of the process for preparing the copolymer of the present invention that the degree of polymerization is monitored by monitoring the viscosity of the reaction mixture. Moreover, the optical refractive index of the reaction mixture is also monitored, and the reaction is not considered completed, nor giving acceptable product unless the reaction mixture has a viscosity within a desired range and an optical refractive index of at least 1.44. The desired viscosity range depends on the nature and composition of the copolymer; for the preferred copolymer having dimethylvinylailoxane end blockers, approximately 15 mol per cent diphenyl siloxane building blocks with the balance being dimethylsiloxane, and a degree of polymerization of approximately 250, the desired viscosity range of the reaction product is approximately 2000 to 2800 centipoise (cp). In this connection it is noted that whereas the aryl content of the copolymer greatly influences the refractive index, the degree of polymerization does not. The degree of polymerization, on the other hand, greatly influences the viscosity of the polymer.
- After the desired level of polymerization and refractive index is achieved, the catalyst is inactivated, neutralized, or removed and the reaction product is carefully filtered, for example on a filter press, to remove any unreacted solid starting materials or other solid impurities.
- After filtration, volatile materials are carefully removed from the copolymer by repeated exposure to vacuum, preferably while the copolymer is in a thin film form. The careful removal of volatiles, commonly termed “stripping”, is consired important for the purpose of obtaining material suitable for use as intraocular lens. The “stripping” is preferably conducted in a state-of-the-art “wipe film evaporator” using large “wipe films” and the process is monitored by gas column chromatography of the removed volatiles. As it will be readily appreciated by those skilled in the art, the removed “volatiles” are residues of starting materials, cyclic and linear oligosiloxanes and the like.
- Moreover, because in virtually every polymerization the molecular weight, or degree of polymerization of the resulting polymeric products follow a substantially bell shaped curve, the crude reaction product copolymer of the present invention also contains products having substantially lesser degree of polymerization, than for example the desired dp of 250 for the preferred embodiment. In this regard it should be understood that a dp of 250 of the preferred embodiment is to be construed as such dp numbers are normally construed in the art of polysiloxane chemistry. A dp of 250 thus means that the average dp of the polymeric product is approximately 250 .
- Stripping of the copolymeric product is repeated several times, preferably three times. This process removes a significant amount of the lower dp copolymers; usually approximately 12 percent by weight of the reaction product is removed by “stripping”.
- It is considered important in the practice of the present invention to monitor viscosity and refractive index at the end of the process of removing volatiles. The refractive index of the copolymer should be at least 1.44. As it was noted above, the desired viscosity depends on the precise nature of the copolymer, for the preferred embodiment the viscosity of the “stripped” copolymer should be approximately 4100 to 5300 cp.
- The elastomeric composition of the present invention contains a trimethylsilyl treated silica reinforcer finely dispersed in the copolymer. Blending trimethylsilyl treated “fume silica” into a polysiloxane copolymer for the purpose of improving the mechanical porperties of the resulting composition per se, is not new in the art. Nevertheless, the composition of the present invention is considered novel and highly unobvious because of the hitherto unattained highly desirable optical and mechanical properties of the reinforced composition.
- In accordance with the invention, the fume silica reinforcer is used in a ratio of approximately 15 to 45 parts by weight of the reinforcer to 100 parts of the copolymer. Fume silica itself is commercially available. Processes for trimethylsilylating the surface of fume silica for the purpose of rendering the silica surface hydrophobic and compatible with polysiloxane polymers are also known and within the skill of the ordinary artisan. U.S. Pat. Nos. 3,341,490 and particularly 3,036,985 refer to and describe such processes for trimethylsilylating fume silica, and the specifications of these two patents are expressly incorporated herein by reference.
- In accordance with the present invention the fume silica reinforcer used for the composition has a surface area of approximately 100 to 450 meter2/gram. For the preferred embodiment of the composition the fume silica has a surface area of approximately 200 meter2/gram, is present in a weight ratio of approximately 27 parts to 100 parts of the copolymer, and is preferably trimethylsilylated with hexamethyldisilazone substantially in the same step where the copolymer is intimately mixed with the silica. The intimate mixing is preferably aided by treating the mixture on a roll mill or like device. After intimate mixing, volatiles, such as unreacted silylating agent, gaseous by-products and water are removed from the mixture by heat and vacuum.
- The intimate mixture of the trimethylsilylated fume silica with the copolymer is commonly termed “base” in the art. For the purpose of making materials suitable for intraocular lens, the base is dispersed in a suitable inert solvent, such as trichlorotrifluoroethene (FREON) and the dispersion is filtered to remove any solid impurities. Thereafter, the solvent is removed by gentle heat and vacuum.
- The resulting, volatile free uncured (not yet cross-linked) and optically clear reinforced silicone elastomer base, has in accordance with the present invention, an optical refractive index of at least 1.44 and a viscosity in such a range which permits intimate mixing of the base with suitable catalyst and cross linking agents, and subsequent manipulation for forming, preferably by molding, into intraocular lenses. The acceptable viscosity range for this purpose is approximately 35,000 to 80,000 cp. For the preferred embodiment of the invention, the refractive index of the uncured base is approximately 1.462±0.003 and the viscosity is in the range of 35,000 to 70,000 cp.
- It is an important feature of the present invention that the uncured base has the inherent characteristics of providing, after suitable curing by cross-linking, physical properties which are highly advantageous for a soft intraocular lens. Thus, after the hereinafter described curing or cross-linking steps, the properties of the resulting cross-linked elastomer include in accordance with the present invention the following:
- an optical refractive index which is at least 1.44;
- a Shore A durometer hardness value of at least 35;
- a tensile strength of at least 500 psi;
- a 150 percent minimum elongation (without damage), and
- a tear strength of at least 20 pounds per lineal inch (pli).
- The above listed properties can be measured in accordance with state-of-the-art technology and instruments in accordance with the respective requirements of standard ASTM test methods. More particularly, the durometer test is performed as ASTM D2240, the tensile and elongation tests as ASTM D412 and the tear strength test as ASTM D624 Die B.
- Preferably, the optical refractive index of the cross linked elastomer obtainable from the base is approximately 1.462, the durometer hardness is approximately between 38 to 40, the tensile strength is approximately between 700 to 750 psi, and the tear strength is approximately 40 pli. In this regard it is noted that cross-linking tends to slightly increase the optical refractive index as compared to the uncured base.
- Preparation of the uncured base for cross-linking is accomplished as follows. The base is filtered once more, preferably through a 325 mesh screen to remove any remaining solid impurities. Thereafter, in accordance with standard practice in the art, the base is divided into two aliquots which preferably are of equal weight. The aliquots are commonly termed “Part A” and “Part B”, or first and second aliquot parts.
- As is known in the art, cross-linking is accomplished by utilizing in a platinum catalyzed reaction the terminal silicon bonded olefinic (vinyl) groups of the base, and silicon bonded hydrogen groups. The silicon bonded olefinic (vinyl) groups are present both in the first and second aliquots of the base.
- Silicon bonded hydrogen groups are added in the practice of the present invention to the second aliquot (Part B) in the form of suitable cross-linking agents. The cross-linking agents per se are known in the art, and may be made in accordance with the teachings of U.S. Pat. No. 3,436,366 the specification of which is incorporated herein by reference.
- Whereas a number of cross-linking agents are suitable for the practice of the invention and can be selected by those skilled in the art, the liquid organohydrogen polysiloxane cross linkers shown in column 2 of the above-noted U.S. Pat. No. 3,436,366 and having the formula (R)a(H)bSiO4-a-b/2 wherein R is simple lower alkyl and a ranges from 1.00 to 2.10 and b ranges from 0.1 to 1.0, are eminently suitable. Particularly suitable is the liquid organohydrogen polysiloxane cross-linker of the above-referenced U.S. Pat. No. 3,436,366 having the formula R2HSiO½, and the liquid cross linker described in Column 4 lines 3-14 of said patent reference wherein the R groups are primarily or predominantly methyl.
- The platinum catalyst can also be selected within the skill of the ordinary artisan, primarily from organo platinum compounds, for example in accordance with the specifications of U.S. Pat. Nos. 2,823,218 and 3,159,601, which are expressly incorporated herein by reference. The platinum catalyst is added to the first aliquot (Part A).
- It is important in accordance with the invention that after mixing of the aliquots (Parts A and Parts B), the cross-linking should not proceed too rapidly at room temperature, thereby allowing at least two, preferably approximately six hours for work time with the mixed aliquots. For this reason, a suitable cross-linking inhibitor, such as 1,2,3,4 tetramethyl-1,2,3,4-tetramethyl cyclotetrasiloxane, is also added to the second aliqout (Part B).
- Although the precise amounts can be adjusted within the skill of ordinary artisan, the organo platinum catalyst is added to the first aliquot in 12 part per million (12 ppm) by weight. The cross-linker is added to the second aliquot in the range of approximately 1 to 6 parts per hundred (1-6 pph) by weight. The above specified inhibitor is also added to the second aliquot in the range of 0.01 to 0.2 parts per hundred by weight.
- It has been found in accordance with the present invention that best results, in terms of desired curing times, are obtained when the amount of inhibitor used in the second aliquot is adjusted on small samples of each batch. The adjustment within the above-noted ranges serves to provide approximately 6 hours of work time at room temperature. In other words, the material should not cure significantly at room temperature within six hours. Before curing or cross-linking, the first and second aliquots are intimately mixed, preferably in equal amounts.
- In addition to the above-described cross-linker and inhibitor, an ultraviolet ray absorbing material is also optionally mixed into the second aliquot in accordance with the teachings of co-pending application for U.S. patent Ser. No. 946,703 filed on Dec. 24, 1986 by Reich et, al, and titled ULTRAVIOLET LIGHT ABSORBING SILICONE COMPOSITIONS.
- The ultraviolet ray absorbing material, which in accordance with teachings of the above-noted patent application is a vinyl functional 2-hydroxybenzophenone, or a vinyl functional benzotriazole is covalently linked to the copolymer of the composition during the cross linking step. Preferably, the ultraviolet absorbing material is 2(2′-hydroxy-3′-t-butyl-5′-vinyl-phenyl)-5-chloro-2H-benzotriazole, and is added in an amount of approximately 0.5 weight percent to the second aliquot, Consequently, in the final cured elastomer, the above-named u. v. absorbent is present in approximately 0.25 per cent (by weight).
- Although the chemical reactions involved in the crosslinking are well known in the art, they are summarized here for the sake of completeness an involving the formation of ethylenic (CH2—CH2) bridges linking one copolymer chain to a polysiloxane cross linking molecule. The polysiloxane cross linker molecule, in turn, is again linked through an ethylenic bridge to a second copolymer chain. In essence, the chemical reaction involves saturation of a vinyl (or other unsaturated) groups of an end blocker with the hydrogen derived from an at least difunctional organohydrogen polysiloxane and formation of a carbon to silicon bond. This reaction is catalyzed by the platinum catalyst.
- The vinyl functional u. v. absorbant reacts with the organohydrogen polysiloxane cross-linking agent in essentially the same way as the vinyl group of the copolymer, and forms a carbon to silicone bond which covalently links the u. v. absorber to the copolymer network.
- Formation of intraocular lens bodies from the elastomeric compositions of the present invention may be accomplished by liquid injection molding or by coat or compression molding of the intimately mixed first and second aliquots. Although these processes are well known in the art, they are briefly summarized by description of the following examples.
- In the liquid injection molding process the mixed aliquots are injected into a hot mold kept at approximately 120 to 150 C. The cross-linking or curing process is then complete in approximately five minutes.
- In the cast or compression molding process, the mixed aliquots are placed into appropriate molds, and the molds are thereafter positioned in an oven heated to approximately 150 C. Under these conditions the cure is complete in approximately 15 to 30 minutes. The cast molding process can also be completed at room temperature in significantly longer time periods.
- The intraocular lenses made in accordance with the present invention have the above-described advantagous optical and Mechanical properties. The unusually high optical refractive index of 1.44 or greater, permits the fabrication of lenses which are at their apex only approximately 1.1 to 1.15 mm thick. This is a significant advance over prior art intraocular lenses which, being made of materials having lower refractive indices, at typically are 1.42 mm thick at their apex.
- An additional advantage of the intraocular lenses made in accordance with the invention is that they do not absorb energy at 1064 nm, thereby permitting follow-up LASER surgery in the eye after implantation of the lens.
- Several modifications of the invention may become readily apparent to those skilled in the art in light of the foregoing disclosure. Therefore the scope of the present invention should be interpreted solely from the following claims. Further particulars of the preferred embodiment of the invention are described in the following description of an example of making the elastomeric compositions of the invention.
- Preparation of Crude Copolymer
- In a 50 gallon reactor (Baker Perkins) mix octaphenylcyclotetrasiloxone (phenyl cyclics) (44.550 kg), octaphenylcyclotetrasiloxone (dimethylcyclics) (93.462 kg) and 1,2-divinyltetramethyldisiloxane (1.116 kg) and heat under agitation and a nitrogen gas blanket to 100 C. When the temperature reaches 100 C add 0.18 per cent (by weight) N-catalyst (about 250 g). Continue heating and stirring and monitor viscosity of samples taken from the reaction mixture. If after 45 minutes there is no change in viscosity, add 0.18 per cent more N-Catalyst (about 75 g). After viscosity change has been observed and the phenyl cyclics have dissolved continue heating and stirring for 3 hours. Then neutralize or destroy the catalyst, for example by bubbling CO2 into the mixture, or heating to 150 C. Viscosity of the cooled reaction mixture should be between 2000 to 2800 cp, the refractive index should be between 1.459 to 1.465.
- Purification of Copolymer
- Filter the cooled reaction mixture on a filter press with a pressure of about 40 psi on five or more filter plates using Zeta Plus filter paper, catalog # A1311-10A. Strip the filtered copolymer at least three times on a “wipe film evaporator”. Monitor the process of stripping by gc, taking samples of 1 g of the volatiles and dissolving the same in 3 g of hexene. Continue stripping until gc indicates adequate devolatilization. Viscosity of stripped copolymer should be between 4100 to 5300 cp, the refractive index should be between 1.459 to 1.465.
- Formulation of Base Including Silica Reinforcer
- In a 50 gallon mixer mix the stripped polymer (75 kg) with hexamethyldisilazane (3.6. kg). Add MS-7 silica (30 kg, surface area 200 m2/g) in increments, and with last silica load add distilled water (1.2 kg), mix well. Thereafter mill mixture twice on three roll mill, and return mixture to 50 gallon mixer. Heat mixer to reach internal temperature of 150 to 200 C. After 30 minutes of heating and stirring at above temperature, apply vacuum and continue heating for 2.5 hours while the mixer reactor is under vacuum. Cool mixture under vacuum. After cooling add more stripped polymer (36.11 kg) as a “cut-back” and mix well. Let a small sample of base settle (unstirred) for about 30 minutes and check viscosity at 25 C. of with Brookfield viscometer, viscosity should be between 35,000 to 70,000 cp.
- Purification of Base
- Disperse the base in trichlorotrifluoroethane (FREON) in a ratio of about 2 gallons of base to 1 gallon of FREON, and add about 0.5 gallon of dictomaceous earth to the dispersion for each 2 gallons of base. Filter the dispersion on a filter press using Zeta Plus filter paper, catalog # A1311-10A. Pressure during filtration should be kept at about 30 psi and should not exceed that value. Clear filrate is required. Place the collected clear filtrate in a reactor, and agitate under nitrogen purge. Apply vacuum gradually while purging slowly with nitrogen. Heat slowly to 110 C. and continue heating under vacuum. Take samples for weight loss test. Continue heating under vacuum until weight loss on samples taken indicates no more than 0.5 per cent loss. Thereafter cool to obtain stripped base.
- Preparation of Aliquots (Parts A and B) Ready for Cross-Linking.
- Screen stripped base through 325 mesh steel wire screen under pressure. Divide the batch into two equal parts, Part A and Part B. Mix into Part A the organoplatinum catalyst to provide 12 parts per million by weight. Take small samples from Part B and mix in the cross-linker (liquid organohydrogen polysiloxone having the structure R2HSiO½with the R groups being predominantly methyl). Optimize the cross linker level, so as to obtain a Shore durometer hardness of approximately 35 (ASTM D2240) in the cross-linked product, Thereafter, gradually add increasing amounts of the inhibitor (1,2,3,4 tetramethyl-1,2,3,4-tetravinyl cyclotetrasiloxane) to Part B and test mixed samples of Parts A and B to obtain a working time of about 6 hours at room temperature. Depending on the above-noted sample teat results, the cross linker is added to Part B to provide 1-6 parts per hundred by weight, and the inhibitor is added to Part B to provide 0.01 to 0.2 parts per hundred by weight.
- Optionally, intimately mix in the u. v. light absorbent 2(2′-hydroxy-3′-t-butyl-5′-vinyl-phenyl)-5-chloro-2H-benzotriazole in an amount which corresponds to approximately 0.5 per cent by weight in Part B.
- Screen Part A and Part B separately from one another on 325 mesh screen to remove any solid contaminants. For cross-linking or curing to obtain intraocular lenses proceed in accordance with procedures required for liquid infection molding, or cast molding.
APPENDIX A DOCKET NO. PATENT # 14101 3,873,696 14104CIP 4,029,817 14106 4,127,674 14108CIP-2 4,395,346 14109 4,230,724 14111 4,244,948 14144 3,888,782 14145 3,822,780 14146 3,954,965 14147 3,966,924 14149 4,197,301 14150 4,255,419 14152 3,749,776 14153 3,733,178 14167 D279,357 14192 4,524,063 14204 4,743,588 16502 4,670,178 16502Reissue RE32,672 16505 4,786,651 16518 4,725,620 16519 4,739,098 16534CIP-1 4,763,651 16540DIV-1 4,786,445 16542FWC 4,759,761 16543 4,704,122 16544 4,834,751 16544DIV1 4,894,062 16544RE-DIV RE34,448 16546 4,790,846 16546DIV-1 4,888,013 16546DIV-2 4,880,426 16546DIV-3 4,938,767 16546DIV-4-CIP-1 5,133,746 16546DIV-4 4,978,354 16546DIV-4-CON-1 5,171,268 16547 4,684,014 16548FWC 4,838,682 16549 4,842,782 16549-CIP-2 5,053,171 16549-CIP-2-DIV1 5,179,262 16549DIV-FWC 5,061,840 16550 4,932,970 16552 4,576,798 16553DIV-1 4,927,947 16553DIV-2 4,980,484 16553FWC 4,923,884 16554 4,597,649 16556FWC-2 5,236,970 16556-FWC-2-DIV-1 5,376,694 16557DIV-1 4,983,580 16557DIV-2 4,981,841 16559CIP 4,868,251 16560 5,149,705 16560DIV 5,246,962 16560DIV-2 5,354,776 16560DIV-3 5,466,690 16561CIP-1 5,089,509 16561CIP-2 5,264,578 16561CIP-DIV 5,234,926 16561CIP-DIV-4 5,380,877 16561CIP-DIV-3 5,348,972 16561DIV-CIP-2 5,468,879 16561CON-DIV-2-CIP 5,354,752 16562 4,810,804 16564CIP&16653CIP 5,134,128 16568 4,759,359 16569 4,834,748 16571 4,817,789 16571DIV 4,928,815 16575 4,208,365 16578 4,452,925 16578REISSUE RE33,997 16580 4,388,428 16582 5,030,231 16582DIV-1 5,088,809 16582CIP-DIV-1 5,196,028 16584 4,517,138 16588 4,551,086 16590 4,468,184 16591 4,647,261 16592 4,681,295 16594DIV-1 4,584,148 16594 4,534,723 16597 4,492,854 16607 DE256,049 16608 DE256,391 16609 DE256,392 16610 DE257,174 16611 DE257,486 16612 DE257,789 16613 DE264,377 16614 DE267,652 16615 DE276,367 16616 3,925,825 16617 3,996,627 16618 3,975,779 16619 3,971,073 16620CIP-1 3,996,626 16620 4,150,471 16621 4,012,823 16622 4,015,965 16623 4,028,082 16624DIV-1 4,071,343 16624 4,025,965 16625 4,014,049 16626 4,139,915 16628 4,079,470 16632 4,838,413 16636 4,845,180 16638FWC-2 5,192,316 16639CON-DIV-1 5,231,113 16639CONT 5,130,335 16640 4,895,868 16640CIP 5,015,658 16642 4,897,079 16643 4,842,602 16643DIV-1 4,888,014 16644FWC 5,300,262 16644 5,076,683 16645 4,935,530 16646 4,860,885 16647CIP-1 5,089,485 16648CIP-1 5,059,611 16649CIP-1 4,957,917 16651CIP 5,424,078 16652CIP-1 5,045,564 16652CIP-2 5,376,676 16654FWC-2-CIP 5,399,573 16655 5,044,743 16657DIV-1 4,328,148 16657DIV-2 4,465,794 16657 4,275,183 16660 4,469,646 16661 4,517,140 16662 4,516,924 16663 4,645,811 16664 4,568,501 16665 4,534,916 16669 4,445,362 16670 4,583,830 16680 4,438,100 16687FWC-DIV-2 5,166,711 16687FWC-DIV-1-CIP 5,225,858 16687FWC-DIV-3 5,270,744 16693 3,739,455 16694 3,829,536 16695 3,827,798 16697 3,751,138 16715 4,983,901 16740 DE315,164 16744-CIP 5,180,721 16744DIV-CIP 5,281,591 16748 4,889,421 16752 5,310,571 16752DIV 5,475,450 16753 4,666,446 16754 5,078,908 16754DIV-2 5,306,440 16754DIV-FWC 5,246,662 16755FWC 5,028,624 16756FWC 5,446,041 16757 4,992,468 16757DIV-1 5,068,252 16758FWC 5,034,413 16760 5,034,406 16761CIP-1 5,112,822 16761CIP-2 5,231,096 16761CIP-2-DIV 5,326,763 16761CIP-2-DIV-2 5,373,010 16761CIP-2-DIV-3 5,418,234 16761DIV-1 5,204,347 16761DIV-2 5,300,504 16761DIV-CIP 5,198,442 16761 5,077,292 16763 5,093.329 16764 5,045,551 16764DIV 5,183,827 16764DIV-2 5,272,156 16764DIV-3 5,407,937 16765 4,980,369 16765CIP-DIV 5,162,546 16765CIP-DIV-2 5,278,318 16766 5,023,341 16766DIV 5,053,523 16766DIV-3 5,248,777 16767 5,279,673 16767DIV-1 5,152,912 16768CIP 5,262,097 16768CIP-DIV 5,344,449 16768 5,147,397 16769CIP 5,135,623 16769 4,997,626 16769DIV 5,320,806 16771 5,171,526 16772 5,145,643 16772CIP 5,277,901 16772CIP-2 5,451,398 16773 4,955,889 16774 5,098,439 16774DIV-FWC 5,222,972 16775DIV 5,194,449 16775 5,011,856 16777CON-DIV 5,258,400 16777CON 5,112,853 16778 5,019,097 16779 5,021,416 16784CON 5,198,545 16784 5,055,467 16785DIV-2-CIP 5,453,434 16785 5,264,449 16786 4,615,702 16787 4,702,865 16788 4,878,910 16796 5,013,744 16796DIV 5,175,185 16796DIV-2 5,264,456 16796DIV-3 5,414,007 16797 5,006,550 16798CIP 5,215,991 16800 4,757,089 16801 5,130,441 16801DIV 5,237,072 16802 5,129,999 16804 5,281,353 16804DIV-1 5,330,752 16805DIV-1 5,312,588 16807 5,111,029 16808 5,202,471 16808CON 5,349,105 16809 5,066,664 16812 5,151,440 16812DIV 5,252,595 16813CIP 5,441,732 16813 5,252,318 16814 5,081,147 16814DIV 5,212,172 16815 5,081,261 16816CIP 5,376,737 16816CIP-2 5,352,753 16816CIP-2-DIV 5,466,768 16816CIP-3 5,397,848 16816 5,164,462 16818CIP 5,395,621 16818FWC 5,362,444 16819 5,013,850 16820CIP 5,474,780 16822 5,238,961 16823 5,037,811 16824 5,043,457 16826 5,173,298 16827 5,100,431 16829 5,139,491 16831 5,323,775 16834 5,296,228 16835 5,275,820 16836 5,276,044 16838 5,091,528 16841 5,270,049 16845 5,183,906 16846 5,225,571 16847 5,169,963 16848 5,171,864 16851CIP 5,262,437 16854 5,312,832 16855 5,288,754 16856CON 5,346,915 16857CON 5,270,002 16860 5,145,644 16864CIP 5,082,954 16864DIV 5,171,863 16864DIV-2 5,322,953 16864DIV-3 5,298,633 16868 5,292,517 16870 5,356,555 16871 5,143,104 16872FWC 5,209,783 16873 5,455,265 16877 5,134,159 16877DIV 5,324,744 16877DIV-2 5,348,975 16878CIP 5,338,480 16878CIP-2 5,324,447 16878CIP-3 5,336,434 16879CON 5,346,895 16881 5,391,590 16883CIP 5,242,449 16883DIV-CIP 5,364,405 16884 5,147,395 16885 5,152,789 16891 5,197,636 16892FWC 5,401,508 16898 5,197,638 16899 5,252,246 16902 5,213,760 16903 5,249,002 16905CIP 5,392,653 16906CIP 5,470,312 16907 5,230,614 16908 5,224,593 16913CIP 5,303,023 16916DIV 5,411,553 16916 5,278,258 16921 5,233,007 16921FWC-DIV 5,420,213 16925 5,462,968 16926 5,326,898 16927CON 5,391,753 16927DIV 5,434,173 16928 5,201,763 16932CIP 5,422,073 16936 5,420,295 16937 5,268,387 16937DIV 5,387,606 16940 5,260,021 16941 5,340,583 16942FWC 5,387,394 16943DIV 5,300,114 16943 5,178,635 16945 5,324,840 16945CIP 5,475,113 16946 5,281,227 16948 5,268,624 16949 5,384,606 16950 5,320,256 16950DIV 5,427,274 16951 5,385,945 16953 5,300,499 16954FWC 5,324,180 16955 5,352,708 16956 5,332,730 16957 5,312,842 16959 5,468,778 16960 5,328,933 16961 5,284,472 16963 5,375,698 16965 5,389,383 16967 5,331,073 16967DIV-1 5,359,021 16971 5,344,959 16972 5,426,118 16973 5,451,605 16974 5,470,999 16977 5,399,561 16982 5,451,686 16983 5,362,647 16984 5,342,293 16985 5,387,180 16988 5,399,586 16990 5,416,106 16991 5,369,127 16992 5,387,608 16992DIV 5,457,131 16995CIP 4,568,517 17000 5,358,473 17003 5,382,599 17005 5,447,650 17010 5,433,745 17012 5,451,237 17013 5,423,929 17018 5,476,872 17022 5,419,775 17024 4,664,667 17025 5,474,979 17042 5,443,178 17050 5,084,012 17051 5,217,465 17104 4,608,049 17117 4,681,102 17162 4,900,366 17164 5,238,153 17167 4,826,001
Claims (40)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/875,410 US20020082691A1 (en) | 1987-02-05 | 2001-06-05 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1102187A | 1987-02-05 | 1987-02-05 | |
US29221288A | 1988-12-29 | 1988-12-29 | |
US56245290A | 1990-08-01 | 1990-08-01 | |
US07/870,799 US5236970A (en) | 1987-02-05 | 1992-04-17 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
US08/086,763 US5376694A (en) | 1987-02-05 | 1993-06-30 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
US08/315,279 US5494946A (en) | 1987-02-05 | 1994-09-29 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
US08/572,768 US5661195A (en) | 1987-02-05 | 1995-12-15 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
US08/866,292 US5869549A (en) | 1987-02-05 | 1997-05-28 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
US09/174,267 US6277147B1 (en) | 1987-02-05 | 1998-10-16 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
US09/875,410 US20020082691A1 (en) | 1987-02-05 | 2001-06-05 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/174,267 Division US6277147B1 (en) | 1987-02-05 | 1998-10-16 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020082691A1 true US20020082691A1 (en) | 2002-06-27 |
Family
ID=27486053
Family Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US07/870,799 Expired - Lifetime US5236970A (en) | 1987-02-05 | 1992-04-17 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
US08/086,763 Expired - Lifetime US5376694A (en) | 1987-02-05 | 1993-06-30 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
US08/315,279 Expired - Lifetime US5494946A (en) | 1987-02-05 | 1994-09-29 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
US08/572,768 Expired - Fee Related US5661195A (en) | 1987-02-05 | 1995-12-15 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
US08/866,292 Expired - Lifetime US5869549A (en) | 1987-02-05 | 1997-05-28 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
US09/174,267 Expired - Fee Related US6277147B1 (en) | 1987-02-05 | 1998-10-16 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
US09/875,410 Abandoned US20020082691A1 (en) | 1987-02-05 | 2001-06-05 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
Family Applications Before (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US07/870,799 Expired - Lifetime US5236970A (en) | 1987-02-05 | 1992-04-17 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
US08/086,763 Expired - Lifetime US5376694A (en) | 1987-02-05 | 1993-06-30 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
US08/315,279 Expired - Lifetime US5494946A (en) | 1987-02-05 | 1994-09-29 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
US08/572,768 Expired - Fee Related US5661195A (en) | 1987-02-05 | 1995-12-15 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
US08/866,292 Expired - Lifetime US5869549A (en) | 1987-02-05 | 1997-05-28 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
US09/174,267 Expired - Fee Related US6277147B1 (en) | 1987-02-05 | 1998-10-16 | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
Country Status (1)
Country | Link |
---|---|
US (7) | US5236970A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030181588A1 (en) * | 2002-03-20 | 2003-09-25 | Yu-Chin Lai | Process for the production of polysiloxane-based polymeric compositions for use in medical devices |
WO2005019306A1 (en) * | 2003-08-14 | 2005-03-03 | Bausch & Lomb Incorporated | Process for the production of high refractive index polysiloxane-based polymeric compositions for use in medical devices |
WO2006002189A1 (en) * | 2004-06-18 | 2006-01-05 | Medennium, Inc. | Photochromic intraocular lenses and methods of making the same |
US20060106458A1 (en) * | 2002-07-30 | 2006-05-18 | Watling Jason | Biomedical compositions |
US20060223964A1 (en) * | 2005-04-01 | 2006-10-05 | Bausch & Lomb Incorporated | Aromatic-based polysiloxane prepolymers and ophthalmic devices produced therefrom |
US7348022B1 (en) | 1999-08-02 | 2008-03-25 | Commonwealth Scientific And Industrial Research Organisation | Biomedical composition |
US20090276042A1 (en) * | 2006-05-03 | 2009-11-05 | Vision Crc Limited | Biological Polysiloxanes |
US8439974B2 (en) | 2006-05-03 | 2013-05-14 | Vision Crc Limited | Adjusted index of refraction of ocular replacement material |
KR102158952B1 (en) | 2020-04-22 | 2020-09-22 | 경동산업 주식회사 | The manufacturing device for synthetic wood and the manufacturing method to use the manufacturing device |
Families Citing this family (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5236970A (en) * | 1987-02-05 | 1993-08-17 | Allergan, Inc. | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
US5476513A (en) * | 1992-02-28 | 1995-12-19 | Allergan, Inc. | Intraocular lens |
US6692525B2 (en) | 1992-02-28 | 2004-02-17 | Advanced Medical Optics, Inc. | Intraocular lens |
US5512609A (en) * | 1992-04-14 | 1996-04-30 | Allergan, Inc. | Reinforced compositions and lens bodies made from same |
JPH07306301A (en) * | 1994-05-13 | 1995-11-21 | Dow Corning Kk | Optical element and its production |
US5620720A (en) * | 1994-11-29 | 1997-04-15 | Allergan | Cast molding of intraocular lenses |
US5716403A (en) * | 1995-12-06 | 1998-02-10 | Alcon Laboratories, Inc. | Single piece foldable intraocular lens |
US5948539A (en) * | 1996-09-04 | 1999-09-07 | Medtronic, Inc. | Medical electrical lead and reinforced silicone elastomer compositions used therein |
US5733334A (en) * | 1996-12-09 | 1998-03-31 | Microoptix | Method and apparatus for adjusting corneal curvature |
US5855604A (en) * | 1996-12-09 | 1999-01-05 | Microoptix, Llc | Method and apparatus for adjusting corneal curvature using a solid filled corneal ring |
US5876439A (en) * | 1996-12-09 | 1999-03-02 | Micooptix, Llc | Method and appartus for adjusting corneal curvature using a fluid-filled corneal ring |
US6228114B1 (en) | 1997-04-01 | 2001-05-08 | Joseph Y. Lee | Adjustable corneal ring |
US6231583B1 (en) | 1997-07-09 | 2001-05-15 | Joseph Y. Lee | Corneal circular channel dissecting device |
US6206919B1 (en) | 1998-01-14 | 2001-03-27 | Joseph Y. Lee | Method and apparatus to correct refractive errors using adjustable corneal arcuate segments |
WO1999052571A1 (en) * | 1998-04-15 | 1999-10-21 | Alcon Laboratories, Inc. | Bicomposite intraocular lens and method for its preparation |
AU737675B2 (en) | 1998-04-15 | 2001-08-30 | Alcon Laboratories, Inc. | Intraocular lens coating compositions |
US6468306B1 (en) | 1998-05-29 | 2002-10-22 | Advanced Medical Optics, Inc | IOL for inhibiting cell growth and reducing glare |
US6329485B1 (en) | 1998-12-11 | 2001-12-11 | Bausch & Lomb Incorporated | High refractive index hydrogel compositions for ophthalmic implants |
US7281795B2 (en) * | 1999-01-12 | 2007-10-16 | Calhoun Vision, Inc. | Light adjustable multifocal lenses |
US20050099597A1 (en) * | 2002-12-24 | 2005-05-12 | Calhoun Vision | Light adjustable multifocal lenses |
SE9900935D0 (en) | 1999-03-16 | 1999-03-16 | Pharmacia & Upjohn Bv | Macromolecular compounds |
US20060238702A1 (en) | 1999-04-30 | 2006-10-26 | Advanced Medical Optics, Inc. | Ophthalmic lens combinations |
US6432137B1 (en) | 1999-09-08 | 2002-08-13 | Medennium, Inc. | High refractive index silicone for use in intraocular lenses |
KR100677782B1 (en) | 2000-01-17 | 2007-02-05 | 제이에스알 가부시끼가이샤 | Process for Preparing the Material for Insulation Film |
US6391230B1 (en) | 2000-02-18 | 2002-05-21 | Bausch & Lomb Incorporated | Intraocular lens manufacturing process |
ATE381303T1 (en) | 2000-05-23 | 2008-01-15 | Amo Groningen Bv | METHOD FOR PRODUCING OPHTALMIC LENSES WITH REDUCED ABBERRATIONS |
US6609793B2 (en) * | 2000-05-23 | 2003-08-26 | Pharmacia Groningen Bv | Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations |
US8020995B2 (en) * | 2001-05-23 | 2011-09-20 | Amo Groningen Bv | Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations |
SE0004393D0 (en) | 2000-11-29 | 2000-11-29 | Pharmacia Groningen Bv | A device for use in eye surgery |
DE10129787A1 (en) * | 2001-06-20 | 2003-01-09 | Coronis Gmbh | Optical component, in particular eye implant |
US6864341B2 (en) * | 2001-11-02 | 2005-03-08 | Bausch & Lomb Incorporated | High refractive index aromatic-based prepolymer precursors |
US6654188B2 (en) * | 2001-12-12 | 2003-11-25 | Lightspan, Llc | Compositions and devices for thermo optically controlled switching and filtering |
US7150759B2 (en) * | 2002-01-14 | 2006-12-19 | Advanced Medical Optics, Inc. | Multi-mechanistic accommodating intraocular lenses |
US7763069B2 (en) | 2002-01-14 | 2010-07-27 | Abbott Medical Optics Inc. | Accommodating intraocular lens with outer support structure |
US6979704B1 (en) | 2002-10-29 | 2005-12-27 | Jds Uniphase Corporation | Optical polymer blend with bimodal particle sizes |
US7896916B2 (en) * | 2002-11-29 | 2011-03-01 | Amo Groningen B.V. | Multifocal ophthalmic lens |
SE0203564D0 (en) | 2002-11-29 | 2002-11-29 | Pharmacia Groningen Bv | Multifocal opthalmic lens |
US7071244B2 (en) * | 2002-12-03 | 2006-07-04 | Staar Surgical Company | High refractive index and optically clear copoly (carbosilane and siloxane) elastomers |
US7662180B2 (en) * | 2002-12-05 | 2010-02-16 | Abbott Medical Optics Inc. | Accommodating intraocular lens and method of manufacture thereof |
US20040153150A1 (en) * | 2003-01-30 | 2004-08-05 | Advanced Medical Optics, Inc. | Composite anterior chamber intraocular lens and method of manufacture thereof |
US7066955B2 (en) * | 2003-09-30 | 2006-06-27 | Advanced Medical Optics, Inc. | High refractive index compositions useful for intraocular lenses and methods for making same |
US20050131535A1 (en) | 2003-12-15 | 2005-06-16 | Randall Woods | Intraocular lens implant having posterior bendable optic |
JP3765425B2 (en) * | 2004-01-26 | 2006-04-12 | 日立工機株式会社 | Portable electric cutting machine |
US8000013B2 (en) * | 2004-09-07 | 2011-08-16 | Ophthonix, Inc. | Tinted lenses that correct for high order aberrations |
US20060050228A1 (en) * | 2004-09-07 | 2006-03-09 | Lai Shui T | Method for stabilizing refractive index profiles using polymer mixtures |
US7371804B2 (en) * | 2004-09-07 | 2008-05-13 | Ophthonix, Inc. | Monomers and polymers for optical elements |
US7922326B2 (en) | 2005-10-25 | 2011-04-12 | Abbott Medical Optics Inc. | Ophthalmic lens with multiple phase plates |
AU2005319678B2 (en) * | 2004-10-25 | 2011-06-30 | Johnson & Johnson Surgical Vision, Inc. | Ophthalmic lens with multiple phase plates |
ATE410483T1 (en) * | 2005-05-26 | 2008-10-15 | Dow Corning | METHOD AND SILICONE ENCAPSULATING COMPOSITION FOR FORMING SMALL SHAPES |
US9636213B2 (en) | 2005-09-30 | 2017-05-02 | Abbott Medical Optics Inc. | Deformable intraocular lenses and lens systems |
US8801781B2 (en) * | 2005-10-26 | 2014-08-12 | Abbott Medical Optics Inc. | Intraocular lens for correcting corneal coma |
WO2007086987A1 (en) * | 2006-01-17 | 2007-08-02 | Dow Corning Corporation | Thermally stable transparent silicone resin compositions and methods for their preparation and use |
CN101336383B (en) * | 2006-02-01 | 2012-05-09 | 陶氏康宁公司 | Impact resistant optical waveguide and method of manufacture thereof |
KR20080104279A (en) * | 2006-02-24 | 2008-12-02 | 다우 코닝 코포레이션 | Light emitting device encapsulated with silicones and curable silicone compositions for preparing the silicones |
US7701641B2 (en) * | 2006-03-20 | 2010-04-20 | Ophthonix, Inc. | Materials and methods for producing lenses |
JP2008110625A (en) * | 2006-10-27 | 2008-05-15 | Toyo Tire & Rubber Co Ltd | Pneumatic tire |
JP2010512225A (en) | 2006-12-12 | 2010-04-22 | ボーシュ アンド ローム インコーポレイティド | Regular polymer systems and intraocular lenses |
US20080161914A1 (en) | 2006-12-29 | 2008-07-03 | Advanced Medical Optics, Inc. | Pre-stressed haptic for accommodating intraocular lens |
US7790829B2 (en) * | 2007-07-13 | 2010-09-07 | Momentive Performance Materials Inc. | Curable and cured silicone rubber compositions and methods therefor |
US20090088842A1 (en) * | 2007-09-27 | 2009-04-02 | Drew Morgan | Intraocular Lens |
US8414646B2 (en) * | 2007-12-27 | 2013-04-09 | Forsight Labs, Llc | Intraocular, accommodating lens and methods of use |
EP2237744B1 (en) | 2008-01-03 | 2018-04-04 | Forsight Labs, Llc | Intraocular accommodating lens. |
US8034108B2 (en) | 2008-03-28 | 2011-10-11 | Abbott Medical Optics Inc. | Intraocular lens having a haptic that includes a cap |
US20090292356A1 (en) * | 2008-05-22 | 2009-11-26 | Michael Hamlin | Reduced profile intraocular lens |
MX2011003671A (en) * | 2008-10-15 | 2011-05-10 | Alcon Inc | Accommodating intraocular lens. |
AU2010266022B2 (en) | 2009-06-26 | 2015-04-23 | Johnson & Johnson Surgical Vision, Inc. | Accommodating intraocular lenses |
AU2010279561B2 (en) | 2009-08-03 | 2014-11-27 | Johnson & Johnson Surgical Vision, Inc. | Intraocular lens for providing accomodative vision |
TWI507183B (en) | 2009-09-04 | 2015-11-11 | Alcon Inc | Intraocular lenses with interlenticular opacification resistance |
CN102883682A (en) | 2010-04-27 | 2013-01-16 | 雷恩斯根公司 | Accommodating intraocular lens device |
US11191637B2 (en) | 2011-09-16 | 2021-12-07 | Rxsight, Inc. | Blended extended depth of focus light adjustable lens with laterally offset axes |
US10874505B2 (en) | 2011-09-16 | 2020-12-29 | Rxsight, Inc. | Using the light adjustable lens (LAL) to increase the depth of focus by inducing targeted amounts of asphericity |
US11135052B2 (en) | 2011-09-16 | 2021-10-05 | Rxsight, Inc. | Method of adjusting a blended extended depth of focus light adjustable lens with laterally offset axes |
US9084674B2 (en) | 2012-05-02 | 2015-07-21 | Abbott Medical Optics Inc. | Intraocular lens with shape changing capability to provide enhanced accomodation and visual acuity |
WO2013172921A1 (en) | 2012-05-14 | 2013-11-21 | Momentive Performance Materials Inc | High refractive index material |
AT13189U1 (en) * | 2012-06-04 | 2013-08-15 | Elast Kunststoffverarbeitungs Gmbh Und Co Keg | Process and device for processing liquid silicone compositions in injection molding machine and injection molding machine |
CN108013952A (en) | 2012-08-31 | 2018-05-11 | Amo格罗宁根私人有限公司 | Polycyclic crystalline lens, system and method for extended focal depth |
JP6625975B2 (en) | 2013-11-01 | 2019-12-25 | レンスゲン、インコーポレイテッド | Accommodating intraocular lens device |
CN106413634B (en) | 2013-11-01 | 2019-03-05 | 雷恩斯根公司 | Double component modulability intraocular lens equipment |
US10004596B2 (en) | 2014-07-31 | 2018-06-26 | Lensgen, Inc. | Accommodating intraocular lens device |
US10647831B2 (en) * | 2014-09-23 | 2020-05-12 | LensGens, Inc. | Polymeric material for accommodating intraocular lenses |
JP6900376B2 (en) | 2015-12-01 | 2021-07-07 | レンスゲン、インコーポレイテッド | Adjustable intraocular lens device |
AU2017218681B2 (en) | 2016-02-09 | 2021-09-23 | Amo Groningen B.V. | Progressive power intraocular lens, and methods of use and manufacture |
EP3463188B1 (en) | 2016-05-27 | 2023-04-26 | LensGen, Inc. | Lens oil having a narrow molecular weight distribution for intraocular lens devices |
US11497599B2 (en) | 2017-03-17 | 2022-11-15 | Amo Groningen B.V. | Diffractive intraocular lenses for extended range of vision |
US11523897B2 (en) | 2017-06-23 | 2022-12-13 | Amo Groningen B.V. | Intraocular lenses for presbyopia treatment |
EP3646110A1 (en) | 2017-06-28 | 2020-05-06 | Amo Groningen B.V. | Diffractive lenses and related intraocular lenses for presbyopia treatment |
AU2018292030B2 (en) | 2017-06-28 | 2024-02-08 | Amo Groningen B.V. | Extended range and related intraocular lenses for presbyopia treatment |
US11327210B2 (en) | 2017-06-30 | 2022-05-10 | Amo Groningen B.V. | Non-repeating echelettes and related intraocular lenses for presbyopia treatment |
WO2019048708A1 (en) | 2017-09-11 | 2019-03-14 | Amo Groningen B.V. | Methods and apparatuses to increase intraocular lenses positional stability |
CN109467703A (en) * | 2018-12-24 | 2019-03-15 | 南京天双辰新材料有限公司 | The removal methods of low molecular weight polycaprolactone siloxanes in a kind of silicon rubber |
CA3166308A1 (en) | 2019-12-30 | 2021-07-08 | Amo Groningen B.V. | Lenses having diffractive profiles with irregular width for vision treatment |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3284406A (en) * | 1963-12-18 | 1966-11-08 | Dow Corning | Organosiloxane encapsulating resins |
US3341490A (en) * | 1964-08-13 | 1967-09-12 | Dow Corning | Blends of two polysiloxane copolymers with silica |
US3457214A (en) * | 1965-12-15 | 1969-07-22 | Gen Electric | Low temperature vulcanizing composition and article made therefrom |
US3436366A (en) * | 1965-12-17 | 1969-04-01 | Gen Electric | Silicone potting compositions comprising mixtures of organopolysiloxanes containing vinyl groups |
US3996189A (en) * | 1975-04-29 | 1976-12-07 | American Optical Corporation | Optically clear filled silicone elastomers |
US3996187A (en) * | 1975-04-29 | 1976-12-07 | American Optical Corporation | Optically clear filled silicone elastomers |
US4418165A (en) * | 1980-06-03 | 1983-11-29 | Dow Corning Corporation | Optically clear silicone compositions curable to elastomers |
US4380643A (en) * | 1981-08-24 | 1983-04-19 | Asahi Glass Company, Ltd. | Benzotriazole compound and homopolymer or copolymers thereof |
US4573998A (en) * | 1982-02-05 | 1986-03-04 | Staar Surgical Co. | Methods for implantation of deformable intraocular lenses |
US4454288A (en) * | 1982-12-02 | 1984-06-12 | Dow Corning Corporation | Surface treatment of inorganic fillers |
US4535141A (en) * | 1984-03-23 | 1985-08-13 | Dow Corning Corporation | Liquid curable polyorganosiloxane compositions |
US4615702A (en) * | 1984-09-10 | 1986-10-07 | Koziol Jeffrey E | Intraocular lens and method of forming the lens |
US4647282A (en) * | 1985-08-27 | 1987-03-03 | Moskovsky Nauchno-Issledovatelsky Institut Mikrokhirurgii Glaza | Material for ocular prosthetics |
US4868251A (en) * | 1986-12-24 | 1989-09-19 | Allergan, Inc. | Ultraviolet light absorbing silicone compositions |
US5236970A (en) * | 1987-02-05 | 1993-08-17 | Allergan, Inc. | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses |
-
1992
- 1992-04-17 US US07/870,799 patent/US5236970A/en not_active Expired - Lifetime
-
1993
- 1993-06-30 US US08/086,763 patent/US5376694A/en not_active Expired - Lifetime
-
1994
- 1994-09-29 US US08/315,279 patent/US5494946A/en not_active Expired - Lifetime
-
1995
- 1995-12-15 US US08/572,768 patent/US5661195A/en not_active Expired - Fee Related
-
1997
- 1997-05-28 US US08/866,292 patent/US5869549A/en not_active Expired - Lifetime
-
1998
- 1998-10-16 US US09/174,267 patent/US6277147B1/en not_active Expired - Fee Related
-
2001
- 2001-06-05 US US09/875,410 patent/US20020082691A1/en not_active Abandoned
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080114090A1 (en) * | 1999-08-02 | 2008-05-15 | Clayton Anthony B | Biomedical Compositions |
US7556822B2 (en) | 1999-08-02 | 2009-07-07 | Commonwealth Scientific And Industrial Research Organisation | Biomedical compositions |
US7348022B1 (en) | 1999-08-02 | 2008-03-25 | Commonwealth Scientific And Industrial Research Organisation | Biomedical composition |
WO2004005375A1 (en) * | 2002-03-20 | 2004-01-15 | Bausch & Lomb Incorporated | Improved process for the production of polysiloxane-based polymeric compositions for use in medical devices |
US6805712B2 (en) | 2002-03-20 | 2004-10-19 | Bausch & Lomb Incorporated | Process for the production of polysiloxane-based polymeric compositions for use in medical devices |
US20030181588A1 (en) * | 2002-03-20 | 2003-09-25 | Yu-Chin Lai | Process for the production of polysiloxane-based polymeric compositions for use in medical devices |
US20060106458A1 (en) * | 2002-07-30 | 2006-05-18 | Watling Jason | Biomedical compositions |
US7452377B2 (en) | 2002-07-30 | 2008-11-18 | Commonwealth Scientific And Industrial Reseach Organization | Biomedical compositions |
WO2005019306A1 (en) * | 2003-08-14 | 2005-03-03 | Bausch & Lomb Incorporated | Process for the production of high refractive index polysiloxane-based polymeric compositions for use in medical devices |
US20060025554A1 (en) * | 2003-08-14 | 2006-02-02 | Yu-Chin Lai | Process for the production of high refractive index polysiloxane-based polymeric compositions for use in medical devices |
WO2006002189A1 (en) * | 2004-06-18 | 2006-01-05 | Medennium, Inc. | Photochromic intraocular lenses and methods of making the same |
US8133274B2 (en) | 2004-06-18 | 2012-03-13 | Medennium, Inc. | Photochromic intraocular lenses and methods of making the same |
US7279538B2 (en) | 2005-04-01 | 2007-10-09 | Bausch & Lomb Incorporated | Aromatic-based polysiloxane prepolymers and ophthalmic devices produced therefrom |
US20060223964A1 (en) * | 2005-04-01 | 2006-10-05 | Bausch & Lomb Incorporated | Aromatic-based polysiloxane prepolymers and ophthalmic devices produced therefrom |
US20090276042A1 (en) * | 2006-05-03 | 2009-11-05 | Vision Crc Limited | Biological Polysiloxanes |
US20110190467A1 (en) * | 2006-05-03 | 2011-08-04 | Vision Crc Limited | Biological Polysiloxanes |
US8439974B2 (en) | 2006-05-03 | 2013-05-14 | Vision Crc Limited | Adjusted index of refraction of ocular replacement material |
KR102158952B1 (en) | 2020-04-22 | 2020-09-22 | 경동산업 주식회사 | The manufacturing device for synthetic wood and the manufacturing method to use the manufacturing device |
Also Published As
Publication number | Publication date |
---|---|
US5494946A (en) | 1996-02-27 |
US5376694A (en) | 1994-12-27 |
US5869549A (en) | 1999-02-09 |
US5236970A (en) | 1993-08-17 |
US6277147B1 (en) | 2001-08-21 |
US5661195A (en) | 1997-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5869549A (en) | Optically clear reinforced silicone elastomers of high optical refractive index and improved mechanical properties for use in intraocular lenses | |
EP0636155B1 (en) | Polysiloxanes, methods of making same and high refractive index silicones made from same | |
US5623029A (en) | Reinforced compositions and lens bodies made from same | |
US7066955B2 (en) | High refractive index compositions useful for intraocular lenses and methods for making same | |
US5397848A (en) | Enhancing the hydrophilicity of silicone polymers | |
EP1243960B2 (en) | Soft contact lens capable of being worn for a long period | |
JP2898664B2 (en) | Crosslinked siloxane-urethane polymer contact lenses | |
US20020071856A1 (en) | Injectable intraocular accommodating lens | |
KR20050085613A (en) | High refractive index polysiloxane prepolymers | |
IE56028B1 (en) | Strong,silicone containing polymers with high oxygen permeability | |
JP2005534737A (en) | Improved biomedical product composition | |
JP2005534737A5 (en) | ||
DE69101464T2 (en) | Unsaturated urea polysiloxanes. | |
JPS6084359A (en) | Modified organopolysiloxane composition | |
AU2001263848B2 (en) | Injectable intraocular lens | |
JP2005516702A (en) | High refractive index flexible silicone | |
AU2001263848A1 (en) | Injectable intraocular lens | |
EP1758946B1 (en) | Novel prepolymers for improved surface modification of contact lenses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BANK OF AMERICA, N.A., NEW YORK Free format text: SECURITY AGREEMENT;ASSIGNORS:ADVANCED MEDICAL OPTICS, INC.;AMO HOLDINGS, LLC;REEL/FRAME:013203/0039 Effective date: 20020621 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, CA Free format text: SECURITY AGREEMENT;ASSIGNOR:ADVANCED MEDICAL OPTICS, INC.;REEL/FRAME:014914/0692 Effective date: 20040625 Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT,CAL Free format text: SECURITY AGREEMENT;ASSIGNOR:ADVANCED MEDICAL OPTICS, INC.;REEL/FRAME:014914/0692 Effective date: 20040625 |
|
AS | Assignment |
Owner name: ADVANCED MEDICAL OPTICS, INC.,CALIFORNIA Free format text: RELEASE OF SECURITY INTEREST AT REEL/FRAME NO. 14914/0692;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:019111/0815 Effective date: 20070402 Owner name: ADVANCED MEDICAL OPTICS, INC., CALIFORNIA Free format text: RELEASE OF SECURITY INTEREST AT REEL/FRAME NO. 14914/0692;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:019111/0815 Effective date: 20070402 Owner name: ADVANCED MEDICAL OPTICS, INC., CALIFORNIA Free format text: RELEASE OF SECURITY INTEREST AT REEL/FRAME NO. 13203/0039;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:019111/0348 Effective date: 20070402 Owner name: AMO HOLDINGS, INC. (FORMERLY KNOWN AS AMO HOLDINGS Free format text: RELEASE OF SECURITY INTEREST AT REEL/FRAME NO. 13203/0039;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:019111/0348 Effective date: 20070402 |